Selected Reports From
The 5th International Congress on
Drug Therapy in HIV Infection,
When To Begin
Therapy: Glasgow & Contrasting Retrovirus Data Presentations
Fifth International Congress on Drug Therapy in HIV Infection - October 22-26, 2000 , Glasgow, Scotland, UK
Written for NATAP by W. David Hardy, M.D.
Retrovirus & Glasgow studies: Initial Response To Therapy Based on CD4 & Viral Load Likelihood of Virologic Failure (500 copies/ml)
Written by Jules Levin
Reports from Glasgow, Scotland
Written by Jules Levin, October 2000
Stopping PI Reverse Lipodystrophy?
- Should lactate levels be
Chronic liver failure and persistent mitochondrial dysfunction 2 years after nucleoside reverse transcriptase inhibitor (NRTI)-induced acute hepatitis and lactic acidemia (abstract P165A).
Dysregulation & Lipodystrophy
Therapy Strategies: Initial, Second Line and Salvage
Reported for NATAP by Graeme Moyle, MD, Chelsea & Westminster Hospital, London, UK
Wednesday Brief Update Report
ABT-378 & Resistance
Bone Problems in HIV
Neviripine & Hepatitis
Immune Function & When to Begin Therapy
vs Nelfinavir (+d4T/3TC)